A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China.

Yijian Chen,Demei Zhu,Yingyuan Zhang,Yongjie Zhao,Gang Chen,Ping Li,Lihong Xu,Ping Yan,M. Anne Hickman,Xiajun Xu,Margaret Tawadrous,Michele Wible

A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China.

2018

Yijian Chen
Demei Zhu
Yingyuan Zhang
Yongjie Zhao
Gang Chen
Ping Li
Lihong Xu
Ping Yan
M. Anne Hickman
Xiajun Xu
Margaret Tawadrous
Michele Wible

Purpose To assess the efficacy and safety of tigecycline in treating complicated intra-abdominal infections (cIAIs) in hospitalized patients in China.

Keywords:

Imipenem/cilastatin
Tigecycline
Abdominal Infection
Diabetes mellitus
Pharmacology
Medicine
Internal medicine
Population
Imipenem
Nausea
Adverse effect
Cilastatin
Vomiting

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations